New treatments in amyotrophic lateral sclerosis.
Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.
Nicholas
N
Maragakis
Jeffrey D
JD
Rothstein
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism*; D000818:Animals; D004268:DNA-Binding Proteins / Q000235:genetics; D004195:Disease Models, Animal; D057180:Frontotemporal Dementia / Q000235:genetics; D005786:Gene Expression Regulation / Q000502:physiology; D005799:Genes, Dominant; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D009154:Mutation / Q000235:genetics; D034702:RNA-Binding Protein FUS / Q000235:genetics; D013482:Superoxide Dismutase / Q000235:genetics; D000072105:Superoxide Dismutase-1
D004268:DNA-Binding Proteins; D034702:RNA-Binding Protein FUS; C000606290:SOD1 protein, human; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1